Navigation Links
Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
Date:7/11/2012

al of Atu027 in patients with solid tumours. Interim results from the trial were announced at the annual meeting of the American Society of Clinical Oncology ('ASCO') in June 2012. The results demonstrated that 10 of the 33 patients treated with Atu027 achieved stable disease at study end (three months after treatment initiation). Patient recruitment into this trial is now complete.  A total of 34 patients have been recruited into the trial which is expected to finish in July 2012 with results available shortly thereafter. To date, Atu027 has been shown to be safe and well tolerated.  The Company plans to use proceeds from this Fundraising to conduct a small Phase Ib trial using Atu027 in combination with a chemotherapy regimen, and subject to the results of this study and any necessary preclinical work, conduct a small Phase IIa trial.

Atu111

Atu111, for the treatment of acute lung injury, is the Company's most advanced drug development candidate

outside oncology. Unlike Silence oncology drug candidates, Atu111 combines Silence' DACC drug delivery system with AtuRNAi. The target for this RNAi therapeutic is undisclosed. However, pre-clinical models using the DACC delivery system have shown sustained knockdown of up to three weeks in the lung endothelium. Silence recently completed proof-of-concept studies in a pre-clinical model of acute lung injury demonstrating  encouraging results using Atu111. Based on these results, Silence plans to conduct further studies in different pre-clinical models of acute lung injury.

Liver projects

Diseases including liver fibrosis and liver cancer continue to be areas of high unmet medical need and their high prevalence in Asia mean they are of increasing interest to pharmaceutical companies. Silence has developed a novel delivery system known as DBTC that enables highly specific delivery of siRNA molecules to cells of the liver including hepatocytes. Silence therefore recently initi
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
2. Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
3. Silence Therapeutics Additional Listing
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
6. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
7. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
8. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
9. United Therapeutics Announces Additional $100 Million Share Repurchase Program
10. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
11. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Research and Markets ... the "International Photonic Integrated Circuit (Monolithic Integration, ... 2019" report to their offering. ... concept of photonic integration traces its roots in ... promise of photonic integration went unexplored and unfulfilled ...
(Date:7/10/2014)... April 15, 2014 -- According to the International ... nuclear security comes from terrorists acquiring sufficient quantities ... construct a crude nuclear explosive device. The IAEA ... trafficking have involved gram-level quantities, which can be ... According to a new study appearing this week ...
(Date:7/10/2014)... June 17, 2014 Using microscopic polymer light ... gases, researchers at MIT,s Quantum Photonics Laboratory have ... in the parts-per-billion range. Optical sensors are ideal ... high signal-to-noise ratio, compact, lightweight nature, and immunity ... sensors had been developed before, the MIT team ...
(Date:7/10/2014)... psychiatric disorders has been extremely challenging because there are ... insufficient to cause disease. Now investigators reporting in the ... Cell Stem Cell describe a strategy that may ... other risk factors or environmental exposures to affect the ... genetic variant that may predispose individuals to schizophrenia. ...
Breaking Biology Technology:International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Sensitive detection method may help impede illicit nuclear trafficking 2Swell new sensors 2New strategy could uncover genes at the root of psychiatric illnesses 2
... Jan. 14 Shamir,Optical Industry Ltd. (Nasdaq: ... and technology to the progressive ophthalmic lens,market, announced ... a dividend,distribution in an aggregate amount of US$ ... January 11, 2008 representative rate of,exchange), or approximately ...
... HAIKOU, China, Jan. 14 /Xinhua-PRNewswire-FirstCall/ --,China Pharma ... CPHI),which develops, manufactures, and markets generic and ... it has retained,HC International, Inc. (HCI) to ... Matthew Hayden and Alan Sheinwald of HCI, ...
... Today, The Woodbridge Group announced,the most ... highest,levels of "Green" Polyurethane Foams. As a ... a patented technology, substitutes petroleum,with plant oils, ... solution for a full line-up of automotive ...
Cached Biology Technology:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3Woodbridge Offers the Broadest Range of BioFoam(TM) 'Green' Polyurethane Automotive Interior Applications 2
(Date:7/10/2014)... -- Fingerprint Cards, (FPC,s) new mobile touch sensor ... Chinese Top 5 smartphone OEM has selected FPC1021 for a ... October 2014.   FPC is proud to announce ... has a planned date for the start of mass production ... phone of 3 million units. The Chinese OEM wants to ...
(Date:7/10/2014)... , July 8, 2014 ... won a new design win (DW). An Asian OEM has ... for mass production start in August 2014.   ... smartphone OEM, which has a planned date for start of ... initial ramp order of SEK 5M, for delivery in the ...
(Date:7/10/2014)... July 9, 2014 The widespread adoption ... large part by meaningful use and related federal ... interact with laboratory information. Now, more than ever, ... of clinical informatics in order to deliver high ... address the educational needs of pathologists in this ...
Breaking Biology News(10 mins):FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4
... for early diagnosis of Alzheimers, Parkinsons and other diseases ... New Jersey Technology Council competition. Based at NJITs ... www.neurotrax.com , a start-up company, was named most likely ... 500 entrepreneurs and investors. NeuroTrax ...
... an essential chemical communicator, carrying impulses from neurons ... the nervous system. Now researchers at the University ... a key component of the relay system that ... findings, which appear in the current issue of ...
... The Global Innovation Imperatives (Gii) project swung into ... session at the American Chemical Societys (ACS) 235th ... collaboration between the ACS Committee on Corporation Associates ... combat worldwide health, environmental and societal issues by ...
Cached Biology News:NJIT start-up company NeuroTrax named best in show 2Researchers 'see' structure of open nicotinic acetylcholine ion channels 2Researchers 'see' structure of open nicotinic acetylcholine ion channels 3At ACS' national meeting, global initiative set to tackle water issues 2
Takara's Mutan-Super Express Km Kit is designed to achieve site-directed mutagenesis in just one day. It is based on Oligonucleotide-directed Dual Amber (ODA) method, using the advantages of LA (Long...
... TriEx Sf9 Cells and TriEx Insect ... from pTriEx baculovirus constructs. This cell/medium combination ... cell growth and high protein expression levels ... pTriEx-1.14 vectors. Please note that our Ready-Plaque ...
...
...
Biology Products: